Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III to the said Regulations, Shree Ganesh Remedies has informed that the Board of Directors of the Company, at its Meeting held today, i.e., on Monday, May 03, 2021 (which commenced at 1l.00 a.m. and concluded at 11:45 am.), have approved/ noted the following: Audited Financial Results for the quarter and Financial year ended March 31, 2021, and recommendation of Final Dividend for the Financial Year 2020-21.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.85 |
| Dr. Reddys Lab | 1236.40 |
| Cipla | 1233.10 |
| Zydus Lifesciences | 937.40 |
| Lupin | 2329.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: